Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Glass House BrandsGLAS -5.62%65 3-Year EPS without NRI Growth Rate is 23.50% as of Jun. 2026, which is at its 10-year median of 23.50. GuruFocus rates GLAS with a GF Score™ of 65/100 and a GF Value™ of $5.12 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 787 Drug Manufacturers companies, Glass House Brands ranks better than 70.39% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 23.50% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 15.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 6 years, the highest 3-Year average EPS without NRI Growth Rate of Glass House Brands was 35.00% per year. The lowest was -3.50% per year. And the median was 23.50% per year.
Glass House Brands (NYSE:GLAS) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Glass House Brands 3-Year EPS without NRI Growth Rate Related Terms
GLAS vs ZTS: 3-Year EPS without NRI Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Glass House Brands's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glass House Brands 3-Year EPS without NRI Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Glass House Brands's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Glass House Brands's 3-Year EPS without NRI Growth Rate falls into.
Glass House Brands 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 23.50% mean?
Glass House Brands (GLAS) has a 3-Year EPS without NRI Growth Rate of 23.50% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Glass House Brands and its competitors. This is near median its historical median of 23.50. According to the industry distribution chart, Glass House Brands ranks #233 out of 787 companies in the Drug Manufacturers industry, placing it in the top 29.6%.
Is Glass House Brands' 3-Year EPS without NRI Growth Rate too high?
Glass House Brands' current 3-Year EPS without NRI Growth Rate of 23.50% is near median its 10-year median of 23.50. The Drug Manufacturers industry median 3-Year EPS without NRI Growth Rate is 9.70. Glass House Brands' value of 23.50% is 142.3% above this industry median. Based on the distribution chart, Glass House Brands ranks #233 out of 787 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Glass House Brands has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glass House Brands' 3-Year EPS without NRI Growth Rate compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Glass House Brands ranks #233 out of 787 companies for 3-Year EPS without NRI Growth Rate. This puts Glass House Brands in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 9.70. Glass House Brands' value of 23.50% is 142.3% above this benchmark. While the company's 10-year median is 23.50 vs. the industry median of 9.70, Glass House Brands has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Drug Manufacturers company?
The median 3-Year EPS without NRI Growth Rate among Drug Manufacturers companies is 9.70, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glass House Brands's current 3-Year EPS without NRI Growth Rate of 23.50% is 142.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Glass House Brands and its competitors. For the Drug Manufacturers industry, the median 3-Year EPS without NRI Growth Rate is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glass House Brands's current 3-Year EPS without NRI Growth Rate is 23.50%, which is near median its own 10-year median of 23.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glass House Brands stock overvalued right now?
Based on GuruFocus' analysis, Glass House Brands (GLAS) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.12, compared to a current price of $9.41 — trading 83.8% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 23.50%, which is near median its 10-year median of 23.50 and 142.3% above the Drug Manufacturers industry median of 9.70. Glass House Brands' overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Glass House Brands (GLAS), the current 3-Year EPS without NRI Growth Rate is 23.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Glass House Brands (GLAS) Overvalued in 2026?
Based on GuruFocus' analysis, Glass House Brands stock appears to be overvalued.
The current stock price of $9.41 is trading 83.8% above its estimated GF Value™ of $5.12.
GuruFocus considers Glass House Brands to be Significantly Overvalued.
Key valuation signals for GLAS:
3-Year EPS without NRI Growth Rate: 23.50% (near median its 10-year median of 23.50)
GF Value™: $5.12 vs. price of $9.41 (83.8% above fair value)
Industry Position: 142.3% above the Drug Manufacturers median (#233 of 787)
No single metric tells the full story. See the GLAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
65GF Score
Get the complete analysis for GLAS
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLAS has been successfully added to your 
